Journal article
Second cancers among long-term survivors of Hodgkin's disease diagnosed in childhood and adolescence
Journal of clinical oncology, Vol.18(12), pp.2435-2443
06/2000
DOI: 10.1200/jco.2000.18.12.2435
PMID: 10856104
Abstract
To quantify the risk of second cancers among long-term survivors of Hodgkin's disease (HD) diagnosed before 21 years of age and to explore sex-, age-, and site-related differences.
We analyzed data from 5,925 pediatric HD patients, including 2,646 10-year and 755 20-year survivors, who were reported to 16 population-based cancer registries in North America and Europe between 1935 and 1994.
A total of 157 solid tumors (observed/expected ratio [O/E] = 7.0; 95% confidence interval [CI], 5.9 to 8.2.) and 26 acute leukemias (O/E = 27.4; 95% CI, 17.9 to 40. 2) were reported. Risk of solid tumors remained significantly increased among 20-year survivors (O/E = 6.6, observed [O] = 40, cumulative risk = 6.5%) and persisted for 25 years (O/E = 4.6, O = 15, cumulative risk = 11.7%). Temporal trends for cancers of thyroid, female breast, bone/connective tissue, stomach, and esophagus were consistent with the late effects of radiotherapy. Greater than 50-fold increased risks were observed for tumors of the thyroid and respiratory tract (one lung and one pleura) among children treated before age 10. At older ages (10 to 16 years), the largest number of second cancers occurred in the digestive tract (O/E = 19.3) and breast (O/E = 22.9). Risk of solid tumors increased with decreasing age at HD on a relative but not absolute scale.
Children and adolescents treated for HD experience significantly increased risks of second cancers at various sites for 2 to 3 decades. Although our results reflect the late effects of past therapeutic modalities, they underscore the importance of lifelong follow-up of pediatric HD patients given early, more aggressive treatments.
Details
- Title: Subtitle
- Second cancers among long-term survivors of Hodgkin's disease diagnosed in childhood and adolescence
- Creators
- Catherine Metayer - Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20892, USACharles F LynchE Aileen ClarkeBengt GlimeliusHans StormEero PukkalaTimo JoensuuFlora E van LeeuwenMars B van't VeerRochelle E CurtisEric J HolowatyMichael AnderssonTom WiklundMary GospodarowiczLois B Travis
- Resource Type
- Journal article
- Publication Details
- Journal of clinical oncology, Vol.18(12), pp.2435-2443
- Publisher
- United States
- DOI
- 10.1200/jco.2000.18.12.2435
- PMID
- 10856104
- ISSN
- 0732-183X
- eISSN
- 1527-7755
- Language
- English
- Date published
- 06/2000
- Academic Unit
- Epidemiology
- Record Identifier
- 9983995021702771
Metrics
19 Record Views